<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">A</forename><surname>Zamò</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University of Würzburg</orgName>
								<address>
									<settlement>Würzburg, Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Diagnostic and Public Health</orgName>
								<orgName type="institution">University of Verona</orgName>
								<address>
									<settlement>Verona</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Comprehensive Cancer Center Mainfranken</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Pischimarov</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University of Würzburg</orgName>
								<address>
									<settlement>Würzburg, Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Comprehensive Cancer Center Mainfranken</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Schlesner</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Theoretical Bioinformatics (B080)</orgName>
								<orgName type="department" key="dep2">Computational Oncology Group</orgName>
								<orgName type="department" key="dep3">German Cancer Research Center (DKFZ)</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">P</forename><surname>Rosenstiel</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Institute for Clinical Molecular Biology</orgName>
								<orgName type="institution">Christian-Albrechts-University</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><surname>Bomben</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Translational Research</orgName>
								<orgName type="institution">CRO</orgName>
								<address>
									<region>Aviano</region>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">H</forename><surname>Horn</surname></persName>
							<affiliation key="aff6">
								<orgName type="institution">Dr Margarete Fischer-Bosch-Institute for Clinical Pharmacology</orgName>
								<address>
									<settlement>Stuttgart</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">T</forename><surname>Grieb</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University of Würzburg</orgName>
								<address>
									<settlement>Würzburg, Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Comprehensive Cancer Center Mainfranken</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">T</forename><surname>Nedeva</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University of Würzburg</orgName>
								<address>
									<settlement>Würzburg, Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Comprehensive Cancer Center Mainfranken</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>López</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Institute for Human Genetics</orgName>
								<orgName type="institution">University Hospital Ulm</orgName>
								<address>
									<settlement>Ulm</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department">Institute for Human Genetics</orgName>
								<orgName type="institution">University Hospital Schleswig-Holstein</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Haake</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Institute for Human Genetics</orgName>
								<orgName type="institution">University Hospital Schleswig-Holstein</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Richter</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Institute for Human Genetics</orgName>
								<orgName type="institution">University Hospital Schleswig-Holstein</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital Schleswig-Holstein</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">L</forename><surname>Trümper</surname></persName>
							<affiliation key="aff10">
								<orgName type="department">Department of Hematology and Medical Oncology</orgName>
								<orgName type="institution">University Hospital</orgName>
								<address>
									<settlement>Göttingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Lawerenz</surname></persName>
							<affiliation key="aff11">
								<orgName type="department" key="dep1">Theoretical Bioinformatics</orgName>
								<orgName type="department" key="dep2">German Cancer Research Center (DKFZ)</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">W</forename><surname>Klapper</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital Schleswig-Holstein</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">P</forename><surname>Möller</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital Ulm</orgName>
								<address>
									<settlement>Ulm</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Hummel</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">Charité-University Hospital Berlin</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Lenze</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">Charité-University Hospital Berlin</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Szczepanowski</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital Schleswig-Holstein</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">L</forename><surname>Flossbach</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University of Würzburg</orgName>
								<address>
									<settlement>Würzburg, Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Comprehensive Cancer Center Mainfranken</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Schreder</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Medizinische Klinik und Poliklinik II</orgName>
								<orgName type="institution">University Hospital Würzburg</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">V</forename><surname>Gattei</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Translational Research</orgName>
								<orgName type="institution">CRO</orgName>
								<address>
									<region>Aviano</region>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Ott</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Department of Clinical Pathology</orgName>
								<orgName type="institution">Robert-Bosch-Krankenhaus</orgName>
								<address>
									<settlement>Stuttgart</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><surname>Siebert</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Institute for Human Genetics</orgName>
								<orgName type="institution">University Hospital Ulm</orgName>
								<address>
									<settlement>Ulm</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department">Institute for Human Genetics</orgName>
								<orgName type="institution">University Hospital Schleswig-Holstein</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Rosenwald</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University of Würzburg</orgName>
								<address>
									<settlement>Würzburg, Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Comprehensive Cancer Center Mainfranken</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">E</forename><surname>Leich</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University of Würzburg</orgName>
								<address>
									<settlement>Würzburg, Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Comprehensive Cancer Center Mainfranken</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff16">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University of Würzburg</orgName>
								<address>
									<addrLine>Josef-Schneider-Straße 2</addrLine>
									<postCode>97080</postCode>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">32EE2BBC35CCF3ED7B557640B3648857</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:40+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Depending on disease stage follicular lymphoma (FL) lack the t(14;18) in ~15-~50% of cases.</s><s>Nevertheless, most of these cases express BCL2.</s><s>To elucidate mechanisms triggering BCL2 expression and promoting pathogenesis in t(14;18)-negative FL, exonic single-nucleotide variant (SNV) profiles of 28 t(14;18)-positive and 13 t(14;18)-negative FL were analyzed, followed by the integration of copy-number changes, copy-neutral LOH and published gene-expression data as well as the assessment of immunoglobulin N-glycosylation sites.</s><s>Typical FL mutations also affected t(14;18)-negative FL.</s><s>Curated gene set/pathway annotation of genes mutated in either t(14;18)-positive or t(14;18)-negative FL revealed a strong enrichment of same or similar gene sets but also a more prominent or exclusive enrichment of immune response and N-glycosylation signatures in t(14;18)negative FL.</s><s>Mutated genes showed high BCL2 association in both subgroups.</s><s>Among the genes mutated in t(14;18)-negative FL 555 were affected by copy-number alterations and/or copy-neutral LOH and 96 were differently expressed between t(14;18)positive and t(14;18)-negative FL (P o0.01).</s><s>N-glycosylation sites were detected considerably less frequently in t(14;18)-negative FL.</s><s>These results suggest a diverse portfolio of genetic alterations that may induce or regulate BCL2 expression or promote pathogenesis of t(14;18)-negative FL as well as a less specific but increased crosstalk with the microenvironment that may compensate for the lack of N-glycosylation.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>Follicular lymphoma (FL) is a germinal center (GC)-derived indolent lymphoma.</s><s>]<ref type="bibr" target="#b3">[4]</ref> Nevertheless, BCL2 expression was observed in ~69-86% of t(14;18)-negative FL in a recent study. <ref type="bibr" target="#b2">3</ref></s><s>The underlying genetic mechanisms leading to BCL2 expression in t(14;18)-negative FL are, however, widely unknown.</s></p><p><s>Previous studies had reported high similarities in gene expression (GE), miRNA and copy-number (CN) profiles between t(14;18)-positive and -negative FL. <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5</ref> Moreover, no significant survival differences were found in patients with advanced stage disease. <ref type="bibr" target="#b2">3</ref></s><s>Nevertheless, a significant enrichment of post-GC, NFkB as well as immune response (IR)-signatures and a downregulation of miR16 were found in t(14;18)-negative FL, suggesting a late GC phenotype in this subgroup. <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5</ref></s><s>Interestingly, these observations were more recently supported by the findings that t(14;18)-negative FL tend to transform into activated B-cell type diffuse large B-cell lymphoma (ABC-DLBCL). <ref type="bibr" target="#b5">6</ref></s><s>he genetic landscape of translocation-positive FL shows a number of genetic alterations, including frequently mutated genes such as KMT2D (MLL2), CREBBP and EZH2 7 and some of these mutations might have prognostic impact. <ref type="bibr" target="#b7">8</ref></s><s>]<ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref> In order to identify alternative mechanisms of BCL2 upregulation and apoptosis resistance and to search for mutations driving pathogenesis of t(14;18)-negative FL, we performed a comprehensive whole-exome (WE) single-nucleotide variant (SNV) profiling of BCL2-translocation-negative FL and complemented our analysis with CN and GE-profiling as well as the assessment of IG N-glycosylation sites.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study cohorts</head><p><s>Fresh frozen (FF) and formalin-fixed paraffin-embedded (FFPE) material was available from 41 FL grades 1-3A.</s><s>BCL2-breakpoints were assessed in either FFPE-or FF-tissue using fluorescence in situ hybridization with BCL2-BAP probes (Abbott Molecular, Ludwigshafen, Germany). <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b13">14</ref></s><s>Since BCL2translocation partners other than IGH are rare in FL, <ref type="bibr" target="#b14">15</ref> we use the terms t(14;18)-positive and t(14;18)-negative FL throughout the manuscript.</s><s>WEsequencing (WES) and SNP6.0-arrays were performed in FF-tumor samples of 11 FL (10 t(14;18)-negative, one t(14;18)-positive) retrieved from the files of the Institute of Pathology, University of Würzburg (Supplementary Table <ref type="table">S1</ref>).</s><s>BLC2 expression in these cases was assessed by immunohistochemistry in FFPE tissue using the clones 124 (DAKO, Glostrup, Denmark) and E17 (Cell Marque, 1:100, Rocklin, CA, USA).</s><s>Whole-genome sequencing was performed within the International Cancer Genome Consortium (ICGC)-MMML-Seq project on FF-material of 30 FL specimens (three t(14;18)negative, 27 t(14;18)-positive) and their corresponding normal controls as described previously. <ref type="bibr" target="#b15">16</ref></s><s>Readily filtered SNV data and information on the BCL2-breakpoint status of the ICGC cohort was provided by the ICGC MMML-Seq consortium for further downstream-analysis (see also Bioinformatics Evaluation).</s><s>Sequencing of the IG variable (IgV)-regions was accomplished using FF-material of 10 t(14;18)-negative FL, also implemented in the WES. <ref type="bibr" target="#b3">4</ref> GE data and the t(14;18)-status of additional 184 FL was available from previous publications. <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b16">17</ref></s><s>The study was approved by the Ethics committees of the Universities Kiel and Würzburg and by the recruiting centers.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Whole-exome sequencing</head><p><s>The WE-libraries (37 Mb, excluding UTRs) were generated starting from 30 ng DNA using the Nextera Enrichment DNA Sample Preparation Kit (Illumina, San Diego, CA, USA) and sequenced with 72 bp paired-end reads on the GAIIx (Illumina) according to the manufacturer's instructions.</s><s>SNP6.0 microarray analysis DNA was isolated from the 10 FF WE-sequenced t(14;18)-negative FL using the Allprep Kit (Qiagen, Hilde, Germany) followed by hybridization to SNP6.0-arrays (Affymetrix, Santa Clara, CA, USA) according to the manufacturer's protocol.</s><s>CN-and loss of heterozygosity (LOH)-data were analyzed using the genotyping console and the CHAS-software from Affymetrix.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sequencing of the immunoglobulin variable region</head><p><s>Ig-sequences were analyzed using the CE-IVD certified LymphoTrack Dx IGH FR1 Assay MiSeq kit and/or the Lymphotrack IGH Somatic Hypermutation Assay-PGM (Invivoscribe, San Diego, CA, USA) according to the manufacturer's protocols.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Bioinformatics evaluation</head><p><s>Raw sequences, revealed by WES, were analyzed using CASAVA (config-ureBclToFastq.pl,</s><s>Illumina), BWA (Burrows-Wheeler Alignment Tool) and the HaploTypeCaller of GATK (Genome Analysis Toolkit) (Supplementary Table <ref type="table" target="#tab_1">S2</ref>).</s><s>Annotations of SNVs (e.g. to amino acid (AA)-exchanges, genesymbols) and mutated genes (e.g.</s><s>curated gene sets (including pathways and signatures), chromosomal sites, gene-families) were performed using SeattleSeq, GSEA, 18 STRING 19 as well as bioDBnet, <ref type="bibr" target="#b19">20</ref> respectively.</s><s>In addition, WES data was analyzed using the published bioinformatics pipeline of the ICGC which was also used for the whole-genome sequencing data. <ref type="bibr" target="#b15">16</ref></s><s>SNPs listed in 1000 genomes and dsbSNPv138 were excluded from the data sets if not specified otherwise.</s><s>SNVs corresponding to the regions of the Nextera design file were extracted from the wholegenome sequencing data and integrated in our analysis.</s><s>The overlap of SNV data with CN/LOH and published GE-microarray data of 147 t(14;18)positive and 17 t(14;18)-negative FL <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b16">17</ref> was accomplished using short phyton-scripts.</s><s>The highest scoring Ig-sequence was analyzed using IG-Blast and gains or losses of N-glycosylation sites were identified by visual inspection as previously described. <ref type="bibr" target="#b11">12</ref></s><s>Clustering analysis was performed with the Cluster software from Michael Eisen. <ref type="bibr" target="#b20">21</ref></s><s>WES and SNP6.0 array data in this paper are deposited in the EGA with accession number EGAS00001002164 (see also Supplementary Methods).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p><s>Low-stage FL are enriched in the t(14;18)-negative FL sub-cohort Out of seven t(14;18)-negative WE-sequenced FL with clinical information available, four patients had early-stage disease (Supplementary Table <ref type="table">S1</ref>).</s><s>Immunohistochemistry analysis of 10 t(14;18)-negative FL collected for WES revealed BCL2 expression in 7/10 (70%) FL.</s></p><p><s>Sequencing data output and quality control WES revealed a ~80-~120 × mean-coverage on target and uniformity at 1 × of at least ~94% (Supplementary Table <ref type="table" target="#tab_1">S2</ref>).</s><s>Excluding SNPs/SNVs listed in 1000 genomes and dbSNPv138, 1250 unique SNVs were called in the 11 WE-sequenced FL cases (10 t(14;18)-negative, 1 t(14;18)-positive) affecting 1057 genes using our in-house bioinformatics pipeline (Supplementary Table <ref type="table" target="#tab_2">S3a</ref>) and 1642 SNVs, affecting 1477 genes using the ICGC pipeline (Supplementary Table <ref type="table" target="#tab_3">S3b</ref>).</s><s>Whole-genome sequencing in the ICGC cohort (3 t(14;18)-negative, 27 t(14;18)-positive FL plus corresponding normal DNA) revealed 1583 SNVs affecting 1305 genes after tumor-normal-subtraction (Supplementary Table <ref type="table" target="#tab_4">S3c</ref>).</s><s>The validation rate of the WES data was 85%.</s><s>A validation approach focusing on genes, called by both bioinformatics pipelines in t(14;18)-negative FL, revealed a validation rate of 98%.</s><s>Curated gene set/pathway annotation was restricted to those genes that carried SNVs called by both bioinformatics pipelines and genes mutated in the cases of the ICGC cohort (t (14;18)-negative: 456 genes (~35 genes/case), t(14;18)-positive: 1102 genes (39 genes/case) (Supplementary Table <ref type="table" target="#tab_5">S4</ref>).</s><s>In total, 148 SNVs of t(14;18)-negative WE-sequenced FL were validated by Sanger sequencing (Supplementary Table <ref type="table">S5</ref>).</s></p><p><s>3]<ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref> Specifically, t(14;18)negative FL of the current cohort were affected by CREBBP in ~38%, STAT6 in ~23%, and EZH2, EP300 and HIST1H1C-E in ~15% of the cases, respectively.</s><s>t(14;18)-negative FL show recurrent mutations in genes with oncogenic potential Around 10% (n = 255) mutated genes were present in both t(14;18)-negative and -positive FL (Supplementary Table <ref type="table">S6a</ref>), while 1435 and 1234 genes were exclusively mutated in t(14;18)negative or -positive FL, respectively (Supplementary Table <ref type="figure">S6b  and c</ref>).</s><s>Of note, MEF2B and BCL2 carried SNVs in 3 out of 28 (~11%) and 13 out of 28 (~46%) t(14;18)-positive FL, respectively, but in none of the t(14;18)-negative FL.</s><s>Recurrent mutations were detected in 193 (Supplementary Table <ref type="figure">S7a and b</ref>) and 118 (Supplementary Table <ref type="figure">S7c and d</ref>) genes in t(14;18)-negative and t(14;18)-positive FL, respectively.</s><s>Out of these, 135 genes were exclusively mutated in t(14;18)-negative FL (Supplementary Table <ref type="table">S7a</ref>) and 106 genes exclusively mutated in t(14;18)-positive FL (Supplementary Table <ref type="table">S7c</ref>).</s><s>Fifty-eight and 12 genes were mutated in both cohorts, but more frequently in t(14;18)-negative and t(14;18)-positive FL, respectively (Supplementary Table <ref type="figure">S7b  and d</ref>).</s><s>Exclusion of point-mutations only called in the 10 t(14;18)negative WE-sequenced FL by only one of the two bioinformatics pipelines or not called in any of the three t(14;18)-negative FL for which germline SNV filtering was available, resulted in a list of 88 genes recurrently mutated in t(14;18)-negative FL.</s><s>0]<ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref><ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref> Finally, focusing on genes that carried SNVs called by IntOGen v 2.2.4 <ref type="bibr" target="#b40">41</ref> revealed high conservation scores according to PhastCons (40.9), were damaging according to PolyPhen or were of biological relevance according to literature-data resulted in a list of 23 core genes more frequently mutated in t(14;18)-negative FL (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Approximately one-third of these genes accumulated in chromosomes 1q, 7 and 15q (Table <ref type="table" target="#tab_1">2</ref>).</s><s>These results suggest that several cancer-associated genes are recurrently mutated in t(14;18)negative FL and less frequently or not at all mutated in t(14;18)positive FL.</s></p><p><s>Enrichment of mutations in apoptosis-related and BCL2-associated genes in t(14;18)-positive and -negative FL Curated gene set annotation of genes affected by SNVs found in either t(14;18)-negative (n = 456) or -positive FL (n = 1102) demonstrated the majority of mutations to be significantly enriched in apoptosis, cell cycle/proliferation, epigenetic processes and immune/inflammatory response signatures (Figure <ref type="figure">1</ref> and Supplementary Table <ref type="figure">S9a and b</ref>) by P-values and FDR-q values of o0.001.</s><s>Specifically, 40/100 top gene sets (40%) were identical and 73-81% identical or similar among t(14;18)-positive and -negative FL.</s><s>A comparison between t(14;18)-negative FL with and without BCL2 expression also revealed an enrichment of apoptosis-signatures in both subgroups; however, the enrichment Table <ref type="table">1</ref>.</s><s>SNV profile of FL with and without t(14;18) with respect to genes recurrently mutated in FL according to the literature <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref> Gene/% t(   <ref type="table">S3</ref>).</s><s>c 1 SNV in a whole-exome sequenced sample that was collected from the files of the institute of pathology in Würzburg and 1 SNV in a sample of the ICGC cohort.</s><s>d 1 sample with indel (indels not reported in Supplementary Table <ref type="table">S3</ref>).</s><s>e Mutated in both subgroups, but more frequently mutated in t(14;18)-negative FL.</s></p><p><s>was more prominent in the cases with BCL2 expression (Supplementary Table <ref type="figure">S10a and b</ref>).</s><s>These observations and the fact that BCL2 is also expressed in t(14;18)-negative FL suggests that BCL2 is an important player in FL pathogenesis.</s><s>Thus, we investigated BCL2 association of mutated genes in all FL subcohorts by STRING analysis.</s><s>Comparing t(14;18)-positive and -negative FL almost all mutated genes clustered together with BCL2 within the same STRING-network using low confidence settings (Table <ref type="table" target="#tab_2">3a</ref> and Supplementary Figure <ref type="figure">S1</ref>).</s><s>At high confidence, the network still comprised 40-50% of mutated genes in both cohorts (Table <ref type="table" target="#tab_2">3a</ref> and Supplementary Table <ref type="table">S11a and b</ref>).</s><s>Moreover, only minor differences were found in the BCL2 association level comparing the WES t(14;18)-negative FL with and without BCL2 expression (Table <ref type="table" target="#tab_3">3b</ref> and Supplementary Table <ref type="figure">11c and d</ref>).</s><s>Among the genes mutated in t(14;18)-negative but BCL2-positive FL having direct BCL2 association at highest confidence were for instance MAPK8 and PTPA/PPP2R4 (Table <ref type="table" target="#tab_4">3c</ref>).</s><s>Overall, these results indicate that both t(14;18)-positive and -negative FL carry mutations in BCL2associated and apoptosis-related genes to a significant extent.</s></p><p><s>Many SNVs detected in t(14;18)-negative FL correlate with differential mRNA expression and other genetic lesions Assuming that genes with a high relevance in FL-pathogenesis may accumulate different genetic alterations, we performed an integrative analysis of SNVs, GE, CNAs and cnLOH.</s><s>An overlap of genes with significantly (P o0.01) different mRNA expression according to previously published data <ref type="bibr" target="#b3">4</ref> with genes harboring non-synonymous SNVs in t(14;18)-negative FL exclusively revealed 96 candidates (Supplementary Table <ref type="table" target="#tab_1">S12a</ref>).</s><s>Subsequently, these genes were scored by different criteria (e.g.</s><s>SNV frequency, biological relevance, BCL2 association, occurrence of CN alteration or cnLOH) and supervised clustering was performed of top-scoring genes (⩾4) such as the TS CDC73, and the MAPK8 and MAP3K9 kinases to visualize differences between FL with and without t(14;18) (Figure <ref type="figure" target="#fig_1">2</ref> and Supplementary Table <ref type="table" target="#tab_1">S12b</ref>).</s><s>Furthermore, we focused on CNAs and cnLOH affecting the same genomic sites targeted by non-synonymous SNVs in the t(14;18)-negative WES cohort and revealed 555 matches (Figure <ref type="figure" target="#fig_2">3</ref> and Supplementary Table <ref type="figure" target="#fig_2">S13a and b</ref>).</s><s>Genes targeted by SNVs and gains were significantly enriched (P o 0.001 and FDRo 0.05) at chromosomes Figure <ref type="figure">1</ref>.</s><s>Signatures/pathways enriched in t(14;18)-positive and -negative FL according to GSEA annotation (C2) of genes affected by SNVs, called in either t(14;18)-positive or -negative FL.</s><s>Only genes were annotated called by both bioinformatic pipelines or in samples of the ICGC data set (t(14;18)-negative: 456 genes, t(14;18)-positive: 1102 genes).</s><s>First 100 pathways with a P-value of o0.001 and an FDR of o 0.05 are depicted (see also Supplementary Table <ref type="table">S9a and</ref>    1q21 and 1q32, 2p22 and 17q25.</s><s>For example, the recurrently mutated methyltransferase and cancer-driver gene ASH1L (1q22) showing SNVs by WES in four t(14;18)-negative FL was in addition affected by both a gain in two patients with SNV and a cnLOH in one additional patient (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Genes affected by SNVs and losses were significantly enriched at 6q22 and 11q23 and genes that were targets of SNVs and cnLOH were for example enriched at 1p21 and 1p34, 5q31 and 9q34 (P ⩽ 0.001 and FDR o0.05) (Figure <ref type="figure" target="#fig_2">3</ref> and Supplementary Table <ref type="table" target="#tab_5">S14a</ref>-c).</s><s>Finally, 49 genes were targets of SNVs, CNA and/or cnLOH and showed a significantly different expression between FL with and without t(14;18) such as ZWINT, associated with kinetochore function, <ref type="bibr" target="#b41">42</ref> the kinase MAPK8 and the tumor suppressor (TS) CDC73.</s><s>In addition 27 out of these 49 candidates (e.g.</s><s>ZWINT, MAPK8 and CDC73) were associated with BCL2 by STRING-network analysis at high confidence (Figure <ref type="figure" target="#fig_2">3</ref> and Supplementary Tables S11a-c, S12 and S13).</s><s>To summarize, several genes, including the kinase MAPK8, the TS CDC73 or the methyltransferase ASH1L, which are targeted by SNVs in t(14;18)-negative FL exclusively in the current study cohort, are in addition differentially expressed between FL with and without t(14;18) and/or affected by CNAs/cnLOH at the same genomic site.</s><s>t(14;18)-negative FL show a reduced level of N-glycosylation Despite the highly similar signature/pathway profile of t(14;18)positive and t(14;18)-negative FL revealed by curated gene set annotation of genes mutated in either t(14;18)-positive or  <ref type="table" target="#tab_1">S12</ref> (columns Y, Z)).</s><s>Notably, the cluster comprises several probesets for some genes.</s><s>The zoomed-in gene list, however, depicts each gene only once.</s><s>-negative FL, we observed a more prominent enrichment of IR/ inflammatory-signatures and an exclusive and significant enrichment of an N-glycosylation pathway in t(14;18)-negative FL, including genes such as UGGT2, MAN1C1 and PDIA3 (Figure <ref type="figure">1</ref> and Supplementary Table <ref type="table">S9a and b</ref>).</s><s>Moreover, a manual screening approach, including all IGV genes affected by mutations in the WES data set revealed AA exchanges to asparagine exclusively in t(14;18)-positive FL (Table <ref type="table" target="#tab_5">4</ref> and Supplementary Figure <ref type="figure" target="#fig_1">S2</ref>).</s><s>Using the highly sensitive CE-IVD certified LymphoTrack assay <ref type="bibr" target="#b42">43</ref> confirmed these preliminary findings in the same cases.</s><s>While IG N-glycosylation sites were present in 79-100% of t(14;18)-positive FL in other study cohorts, <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b43">44</ref> we observed new N-glycosylation sites in only one out of six (~17%) successfully sequenced t(14;18)negative FL (Table <ref type="table" target="#tab_5">4</ref>), despite a comparable IG gene somatic hypermutation-level between t(14;18)-positive and -negative FL.</s></p><p><s>Recapitulating these findings, we found that SNVs are enriched in genes associated with the microenvironment and N-glycosylation in t(14;18)-negative FL.</s><s>However, at the same time we learned that the gain of novel Ig N-glycosylation sites is a less common event in t(14;18)-negative FL as compared with t(14;18)-positive FL.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>FL may be even more heterogeneous than previously assumed.</s><s>Around 15% of stage III/IV and ~50% of stage I/II lack the t(14;18); however, the majority of t(14;18)-negative FL express BCL2 by so far unknown mechanisms. <ref type="bibr" target="#b2">3</ref></s><s>In addition, previous investigations showed that the delineation of t(14;18)-positive and -negative FL might be clinically relevant, <ref type="bibr" target="#b5">6</ref> and non IG markers for the detection of minimal residual disease (MRD) in t(14;18)-negative FL do not exist, so far.</s><s>Therefore, we performed a comprehensive integrative analysis, including SNV-, CNA/cnLOH-and GE-profiling, to obtain a clearer view on the pathogenesis of t(14;18)-negative FL.</s></p><p><s>6]<ref type="bibr" target="#b46">[47]</ref><ref type="bibr" target="#b47">[48]</ref><ref type="bibr" target="#b48">[49]</ref> In contrast, mutations in PTPRD reported in nodal marginal zone lymphoma <ref type="bibr" target="#b48">49</ref> were not found in any FL of the current study.</s><s>Moreover, although the called SNVs affected different genes, they accumulated in the same or similar signatures in t(14;18)-positive and -negative FL.</s></p><p><s>The significant enrichment of apoptosis-associated genes in t(14;18)-positive and t(14;18)-negative FL, which were targeted by SNVs in an almost mutually exclusive fashion in the two subgroups, led us to speculate that some of these genes might be regulated by BCL2 in t(14;18)-positive FL or trigger BCL2 expression in t(14;18)-negative FL.</s><s>In order to clarify to which level the mutated genes show BCL2 association, we predicted bioinformatic signaling networks encompassing genes that were mutated in either t(14;18)-positive or -negative FL and BCL2.</s><s>Even at high confidence, almost half of the genes clustered together with BCL2 within the same network in both cohorts and only minor differences were observed in the BCL2 association level between the two groups.</s><s>Moreover, the BCL2 association level between t(14;18)-negative FL with and without BCL2 expression was similar.</s><s>One resilient hypothesis is that BCL2-negative FL bypass the need for BCL2 by using other anti-apoptotic mechanisms, as shown by several lesions in genes belonging to apoptosis-regulating pathways.</s><s>In contrast to this, mutations in genes directly associated with BCL2 at high confidence in t(14;18)negative FL with BCL2 expression such as MAPK8 and PPP2R4/ PTPA might indeed trigger BCL2 expression and compensate for the t (14;18).</s><s>A MAPK8-signature was for instance enriched upon the annotation of mutated genes in t(14;18)-negative FL expressing BCL2 and knockdown of PTPA induces apoptosis, suggesting that PTPA has-similar to BCL2-anti-apoptotic properties. <ref type="bibr" target="#b49">50,</ref><ref type="bibr" target="#b50">51</ref></s><s>Moreover, both genes were in addition affected by cnLOH.</s><s>However, SNVs and cnLOH did not co-occur in the same patient but affected different patients.</s></p><p><s>Overall, the similar pathway/signature usage in t(14;18)-positive and -negative FL suggests parallels in the molecular pathogenesis and a central role for anti-apoptotic mechanisms in the pathogenesis of both t(14;18)-positive and t(14;18)-negative FL.</s></p><p><s>Another novel finding of this study was the detection of recurrent mutations in well-defined cancer-associated genes only present in t(14;18)-negative FL that therefore may specifically trigger tumor pathogenesis in this subgroup.</s><s>Among these are the cancer-driver genes ASH1L, ATFIP, PCLO and LRP6 which were affected by SNVs in conserved regions leading to structural changes according to bioinformatics predictors. <ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b51">52</ref></s><s>In addition to those, many genes carrying both an SNV and a CNA in the current data set were significantly enriched in chromosomal regions previously described to be frequently altered in FL, for example, del6q, +1q, +17q and +2p. <ref type="bibr" target="#b52">53</ref></s><s>oreover, 49 core genes were identified in t(14;18)-negative FL that carried not only an SNV but also a CNA or cnLOH and were shown to be differentially expressed between FL with and without t(14;18) such as the kinase MAPK8 and the TS CDC73, possibly underlining special importance of these genes in the pathogenesis of t(14;18)-negative FL.</s><s>Most interestingly, the cancer-driver gene ASH1L (1q22), a methyltransferase, carried a SNV in four patients by WES.</s><s>Two of these patients also showed a CN gain and an additional patient showed a cnLOH affecting ASH1L.</s><s>Sanger sequencing allowed the detection of two of the SNVs, while the other two mutations were probably affecting a minor subclone not detectable by Sanger sequencing.</s><s>Thus, in total 5 out of 10 t(14;18)-negative FL patients with both sequencing and CNA/ cnLOH data available were affected by genetic aberrations in ASH1L.</s><s>Since FL has been described to be a tumor of the epigenome, <ref type="bibr" target="#b6">7</ref> due to its frequent occurrence of mutations in methyltransferases such as EZH2 and other proteins of the epigenome, this finding might be of special interest.</s><s>ASH1L mutations were reported in context with other cancer entities, <ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b54">54,</ref><ref type="bibr" target="#b55">55</ref> but to our knowledge not reported in FL, so far.</s><s>In consideration of the small study cohorts one, however, has to  <ref type="bibr">(ref. 58)</ref> by permission from BLOOD, the American Society of Hematology.</s></p><p><s>be aware that the statistical power to detect differentially mutated genes is limited, especially in the context of multiple testing.</s><s>Therefore, these results warrant further validation in more extensive FL series.</s></p><p><s>In support of previous findings and the theory of a late GC phenotype in t(14;18)-negative FL, <ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref> we also observed a significant enrichment of SNVs in genes associated with NFΚBactivation in t(14;18)-negative FL as well as mutations in genes associated with GCB-DLBCL in t(14;18)-positive FL <ref type="bibr" target="#b56">56</ref> (Supplementary Figure <ref type="figure" target="#fig_2">S3</ref> and Supplementary Table <ref type="table">S15</ref>).</s></p><p><s>The more prominent occurrence of mutations in genes associated with N-glycosylation in t(14;18)-negative FL that led to a significant enrichment of a N-glycosylation pathway in this sub-cohort by annotating genes exclusively mutated in t(14;18)negative FL, gave rise to the hypothesis of differences in the usage of N-glycosylation between t(14;18)-positive and -negative FL.</s><s>Indeed, we found gains of new N-glycosylation sites less frequently in t(14;18)-negative FL, <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b43">44</ref> suggesting that the SNVs that accumulated in genes associated with N-glycosylation in t(14;18)-negative FL might be responsible for this lack.</s><s>However the level of on-target somatic hypermutation, involving IG genes, was high and comparable to that seen for a historical FL cohort. <ref type="bibr" target="#b57">57</ref></s><s>he on-target somatic hypermutation in translocation-negative FL therefore seems to be less prone to cause new N-glycosylation sites, probably indicating a different type of selective pressure which might rely more on classical antigen presentation than on lectin binding.</s><s>These observations, together with the more prominent enrichment of mutations in genes associated with IR/inflammation or the enrichment of SNVs in genes associated with NFkB-signaling in t(14;18)-negative FL, may suggest that at least some cases of this sub-cohort might bypass lectin-mediated BCR-signaling via N-glycosylation 58 by a more diffuse, increased or aberrant signaling stemming from the bystander cells/microenvironment or NFkB-associated genes, supporting previous observations of more impact of the enriched microenvironment and a late GC phenotype in t(14;18)-negative FL <ref type="bibr" target="#b3">4</ref> (Figure <ref type="figure" target="#fig_3">4</ref>).</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>Figure1.</s><s>Signatures/pathways enriched in t(14;18)-positive and -negative FL according to GSEA annotation (C2) of genes affected by SNVs, called in either t(14;18)-positive or -negative FL.</s><s>Only genes were annotated called by both bioinformatic pipelines or in samples of the ICGC data set (t(14;18)-negative: 456 genes, t(14;18)-positive: 1102 genes).</s><s>First 100 pathways with a P-value of o0.001 and an FDR of o 0.05 are depicted (see also Supplementary TableS9a and b).</s><s>Venn diagram: InteractiVenn (http://www.interactivenn.net).</s></p></div></figDesc><graphic coords="4,86.97,59.30,430.81,244.69" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Supervised clustering of mutated genes differentially expressed between t(14;18)-positive and -negative FL (P o0.01).</s><s>Depicted are genes with scores ⩾ 4 (see Supplementary TableS12(columns Y, Z)).</s><s>Notably, the cluster comprises several probesets for some genes.</s><s>The zoomed-in gene list, however, depicts each gene only once.</s></p></div></figDesc><graphic coords="5,52.89,213.17,480.02,321.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. Overlap of CNAs and cnLOH with SNVs detected in t(14;18)-negative FL at the same genomic site.</s><s>This overlap revealed 555 candidates.</s><s>Significant hotspots (circled in red) were assessed by GSEA C1 anotation.</s></p></div></figDesc><graphic coords="6,92.35,59.30,419.98,375.82" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4. Hypothesis-driven model of N-glycosylation signaling in FL with and without t(14;18) based on current knowledge. 3-6,58</s><s>Figure adapted and modified from Matthew P Strout, BLOOD, 2015(ref. 58)</s><s> by permission from BLOOD, the American Society of Hematology.</s></p></div></figDesc><graphic coords="7,70.92,59.30,444.02,252.11" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s>14;18)-neg FL t(14;18)-pos FL FL (lit) SMZL (lit) NMZL (lit) EMZL-MALT (lit) ABC-DLBCL (lit) DLBCL, NOS (lit) GCB-DLBCL (lit)</s></p></div></figDesc><table><row><cell>KMT2D (MLL2)</cell><cell>~8</cell><cell>~46</cell><cell>67-89</cell><cell>11</cell><cell>34</cell><cell></cell><cell>41</cell><cell>32-38</cell><cell>46</cell></row><row><cell>BCL2</cell><cell>0</cell><cell>~46</cell><cell>25-76</cell><cell>0</cell><cell>0</cell><cell></cell><cell>1</cell><cell></cell><cell>24-45</cell></row><row><cell>TNFRSF14</cell><cell>~15</cell><cell>~18</cell><cell>25-36</cell><cell>0</cell><cell>11</cell><cell></cell><cell>2</cell><cell>22</cell><cell>13-17</cell></row><row><cell>CREBBP</cell><cell>~38</cell><cell>~61</cell><cell>33-75</cell><cell>5</cell><cell>6</cell><cell></cell><cell>6-13</cell><cell></cell><cell>31-32</cell></row><row><cell>HIST1H1C-E</cell><cell>~15</cell><cell>~15</cell><cell>8-28</cell><cell>0</cell><cell>9</cell><cell></cell><cell>25</cell><cell></cell><cell>9</cell></row><row><cell>EZH2</cell><cell>~15</cell><cell>~14</cell><cell>12-31</cell><cell>0</cell><cell>0</cell><cell></cell><cell>0</cell><cell></cell><cell>18-22</cell></row><row><cell>TNFAIP3/A20</cell><cell>~8</cell><cell>0</cell><cell>3-11</cell><cell>7-8</cell><cell>9-33</cell><cell>15-30</cell><cell>15-30</cell><cell></cell><cell>2-11</cell></row><row><cell>MEF2B</cell><cell>0</cell><cell>~9</cell><cell>10-31</cell><cell>0</cell><cell>0</cell><cell></cell><cell>12</cell><cell>11</cell><cell>23</cell></row><row><cell>EP300</cell><cell>~15</cell><cell>~7</cell><cell>9-23</cell><cell>5</cell><cell>6</cell><cell></cell><cell>4-15</cell><cell></cell><cell>2-14</cell></row><row><cell>STAT6</cell><cell>~23</cell><cell>~14</cell><cell>9-12</cell><cell>0</cell><cell>0</cell><cell></cell><cell>0</cell><cell></cell><cell>14</cell></row><row><cell>IRF8</cell><cell>~15</cell><cell>~4</cell><cell>6-9</cell><cell>0</cell><cell>0</cell><cell></cell><cell>9</cell><cell></cell><cell>15</cell></row><row><cell>TP53</cell><cell>~8</cell><cell>~4</cell><cell>5-12</cell><cell>15</cell><cell>0</cell><cell>19</cell><cell>18-19</cell><cell></cell><cell>16-26</cell></row><row><cell cols="7">Framed in bold: genes recurrently mutated in FL but not in marginal zone lymphoma (MZL).</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Reduced list of recurrently mutated genes that were exclusively or more frequently mutated in t(14;18)-negative FL first step, point-mutations only called in the 10 t(14;18)-negative in-house FL by only one of the two bioinformatics pipelines were excluded.Subsequently, only SNVs were kept that were called by IntOGen v 2.2.4,located in highly conserved regions according to PhastCons, leading to a structural change according to PolyPhen or affected genes of biological relevance according to the literature.Finally, only genes are depicted in this list that carry SNVs validated by Sanger sequencing (see Supplementary TableS5).</s><s>Of note, validation was limited to samples retrieved from the files of the Institute of Pathology in Würzburg.</s></p></div></figDesc><table><row><cell>Gene</cell><cell>Gain</cell><cell>Loss</cell><cell>cnLOH</cell><cell>Chr</cell><cell>PhastCons (sample 1, 2, ...)</cell><cell>Polyphen (sample 1, 2, ...)</cell></row><row><cell>SUMF2 a</cell><cell>Yes</cell><cell>No</cell><cell>No</cell><cell>7</cell><cell>0.99, 1.00</cell><cell>Damaging, damaging</cell></row><row><cell>NEO1 a</cell><cell>No</cell><cell>No</cell><cell>Yes</cell><cell>15</cell><cell>0.99, 1.00</cell><cell>Damaging, damaging</cell></row><row><cell>MYO10 a</cell><cell>No</cell><cell>No</cell><cell>No</cell><cell>5</cell><cell>1.00, 1.00</cell><cell>Damaging, damaging</cell></row><row><cell>ATF7IP a</cell><cell>No</cell><cell>No</cell><cell>Yes</cell><cell>12</cell><cell>0.99, 0.96</cell><cell>Damaging, damaging</cell></row><row><cell>SOGA2 a</cell><cell>No</cell><cell>No</cell><cell>No</cell><cell>18</cell><cell>0.79, 0.98</cell><cell>Damaging, damaging</cell></row><row><cell>RNF169 a,b</cell><cell>No</cell><cell>No</cell><cell>Yes</cell><cell>11</cell><cell>1.00, 1.00</cell><cell>Damaging, damaging</cell></row><row><cell>CUBN a</cell><cell>No</cell><cell>No</cell><cell>No</cell><cell>10</cell><cell>0.49, 0.35</cell><cell>Damaging, damaging</cell></row><row><cell>DOCK10 a</cell><cell>No</cell><cell>No</cell><cell>No</cell><cell>2</cell><cell>0.01, 1.00</cell><cell>Damaging, damaging</cell></row><row><cell>ASH1L a</cell><cell>Yes</cell><cell>No</cell><cell>Yes</cell><cell>1</cell><cell>1.00, 1.00</cell><cell>Damaging, damaging</cell></row><row><cell>CENPI a,c</cell><cell>No</cell><cell>No</cell><cell>Yes</cell><cell>X</cell><cell>1.00</cell><cell>Damaging</cell></row><row><cell>FAM35A a,d</cell><cell>Yes</cell><cell>No</cell><cell>No</cell><cell>10</cell><cell>0.66, 0.24</cell><cell>Damaging, damaging</cell></row><row><cell>MCTP2 a</cell><cell>No</cell><cell>No</cell><cell>No</cell><cell>15</cell><cell>0.65, 0.00</cell><cell>Damaging, benign</cell></row><row><cell>LRP6 a</cell><cell>No</cell><cell>No</cell><cell>No</cell><cell>12</cell><cell>0.99, 1.00</cell><cell>Damaging, benign</cell></row><row><cell>CEP78 a</cell><cell>No</cell><cell>No</cell><cell>No</cell><cell>9</cell><cell>0.91, 1.00</cell><cell>Benign, damaging</cell></row><row><cell>ZBED5 a</cell><cell>No</cell><cell>No</cell><cell>No</cell><cell>11</cell><cell>1.00, 1.00</cell><cell>Damaging, benign</cell></row><row><cell>MLH3 a,c</cell><cell>No</cell><cell>No</cell><cell>No</cell><cell>14</cell><cell>0.45</cell><cell>Benign</cell></row><row><cell>ANK2 a</cell><cell>Yes</cell><cell>No</cell><cell>No</cell><cell>4</cell><cell>1.00, 0.24, 1.00, 0.97</cell><cell>Damaging, benign, damaging, benign</cell></row><row><cell>MS4A1 a</cell><cell>No</cell><cell>No</cell><cell>No</cell><cell>11</cell><cell>0.00, 0.00</cell><cell>Benign, benign</cell></row><row><cell>PCLO a</cell><cell>No</cell><cell>No</cell><cell>No</cell><cell>7</cell><cell>1.00, 0.00</cell><cell>Damaging, benign</cell></row><row><cell>PLEKHH2 a</cell><cell>Yes</cell><cell>No</cell><cell>No</cell><cell>2</cell><cell>0.99, 1.00</cell><cell>Damging, damaging</cell></row><row><cell>SCIN a</cell><cell>No</cell><cell>No</cell><cell>No</cell><cell>7</cell><cell>0.99, 0.00</cell><cell>Damaging, benign</cell></row><row><cell>STARD9 a</cell><cell>No</cell><cell>No</cell><cell>Yes</cell><cell>15</cell><cell>0.01, 0.00</cell><cell>Unknown, unknown</cell></row><row><cell>USH2A e</cell><cell>No</cell><cell>No</cell><cell>No</cell><cell>1</cell><cell>1.00</cell><cell>Damaging</cell></row><row><cell>In a</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>a Exclusively mutated in t(14;18)-negative FL. b SNV listed in dbSNP138 (not listed in Supplementary Table</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3a .</head><label>3a</label><figDesc><div><p><s>Amount of mutated genes with BCL2 association (directly or</s></p></div></figDesc><table><row><cell cols="3">Confidence BCL2 association of genes mutated in FL with or without</cell></row><row><cell></cell><cell>t(14;18)</cell><cell></cell></row><row><cell></cell><cell>t(14;18)-negative FL</cell><cell>t(14;18)-positive FL</cell></row><row><cell></cell><cell>(n = 1435) (%)</cell><cell>(n = 1234) (%)</cell></row><row><cell>Low</cell><cell>~99</cell><cell>~96</cell></row><row><cell>Medium</cell><cell>~83</cell><cell>~76</cell></row><row><cell>High</cell><cell>~46</cell><cell>~40</cell></row><row><cell>Highest</cell><cell>~29</cell><cell>~20</cell></row></table><note><p><s>indirectly) according to STRING analysis in t(14;18)-negative and t(14;18)-positive FL</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3b .</head><label>3b</label><figDesc><div><p><s>Amount of mutated genes with BCL2 association (directly or</s></p></div></figDesc><table><row><cell cols="3">indirectly) according to STRING analysis in t(14;18)-negative FL with</cell></row><row><cell cols="2">and without BCL2 expression</cell><cell></cell></row><row><cell>Confidence</cell><cell cols="2">BCL2 association of genes mutated in t(14;18)-neg</cell></row><row><cell></cell><cell cols="2">FL with or without BCL2-expression</cell></row><row><cell></cell><cell>t(14;18)-negative</cell><cell>t(14;18)-negative</cell></row><row><cell></cell><cell>FL − BCL2 (%)</cell><cell>FL +BCL2 (%)</cell></row><row><cell>Low</cell><cell>~57</cell><cell>~64</cell></row><row><cell>Medium</cell><cell>~24</cell><cell>~36</cell></row><row><cell>High</cell><cell>~12</cell><cell>~12</cell></row><row><cell>Highest</cell><cell>0</cell><cell>~1</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 3c .</head><label>3c</label><figDesc><div><p><s>Mutated genes with direct BCL2 association at highest confidence in t(14;18)-negative FL</s></p></div></figDesc><table><row><cell>#node1</cell><cell>node2</cell><cell>score40.9</cell><cell>CN_gain</cell><cell>CN_loss</cell><cell>cnLOH</cell><cell>differential_GE_po0.01</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 4 .</head><label>4</label><figDesc><div><p><s>Level of amino acid (AA)-exchange according to the whole exome and extracted-whole-genome data and the level of SHM and gained N-glycosylation sites according to the LymphoTrack assay in t(14;18)-negative FL as compared to published results of historical FL-cohorts</s></p></div></figDesc><table><row><cell></cell><cell>SHM</cell><cell>AA-exchange ?</cell><cell>N-glycosylation</cell></row><row><cell></cell><cell></cell><cell>4 N</cell><cell>sites</cell></row><row><cell>t(14;18)-neg</cell><cell>5.8-10.6%</cell><cell>0/13 (0%)</cell><cell>1/6 (~17%)</cell></row><row><cell>t(14;18)-pos/Historical</cell><cell cols="3">2.7-13.5% a 6/28 (~21%) 55/70 (79%) b</cell></row><row><cell>FL cohort</cell><cell></cell><cell></cell><cell>24/24 (100%) c</cell></row><row><cell cols="4">Abbreviation: SHM, somatic hypermutation. a Aarts et al. 57 b Zhu et al. 12</cell></row><row><cell>c Zabalegui et al. 44</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGEMENTS</head><p><s>AZ was supported by the Alexander von Humboldt Stiftung and GO and HH by the Robert-Bosch-Stiftung.</s><s>This work was supported in part by the German Ministry for Education and Science (BMBF (ICGC MMML-Seq (01KU1002A-J) and ICGC DE-mining (01KU1505G) consortia)).</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONFLICT OF INTEREST</head><p><s>The authors declare no conflict of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Follicular lymphoma</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">L</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Swerdlow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Jaffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Swerdlow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Campo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">L</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Jaffe</surname></persName>
		</author>
		<author>
			<persName><surname>Pileris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Stein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues</title>
				<imprint>
			<date type="published" when="2008">2008</date>
			<biblScope unit="page" from="220" to="226" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Horsman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Okamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Ludkovski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Le</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Harder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gesk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Haematol</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="424" to="433" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus</title>
		<author>
			<persName><forename type="first">E</forename><surname>Leich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hoster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wartenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Unterhalt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Siebert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Koch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="854" to="860" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations</title>
		<author>
			<persName><forename type="first">E</forename><surname>Leich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Salaverria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zettl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Moreno</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="826" to="834" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype</title>
		<author>
			<persName><forename type="first">E</forename><surname>Leich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zamo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Horn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Haralambieva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Puppe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Gascoyne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="5550" to="5558" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Cell of origin of transformed follicular lymphoma</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kridel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mottok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Farinha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ben-Neriah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ennishi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="2118" to="2127" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Pathogenesis of follicular lymphoma</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kridel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Sehn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Gascoyne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="3424" to="3431" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Integration of gene mutations in risk prognostication for patients receiving firstline immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry</title>
		<author>
			<persName><forename type="first">A</forename><surname>Pastore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Jurinovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kridel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hoster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Staiger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Szczepanowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Oncol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="1111" to="1122" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins</title>
		<author>
			<persName><forename type="first">V</forename><surname>Coelho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Krysov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Ghaemmaghami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Emara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Potter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="18587" to="18592" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>Linley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Krysov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ponzoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Packham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Stevenson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="1902" to="1910" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Mccann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Ottensmeier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Callard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Radcliffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Harvey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Dwek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Immunol</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1567" to="1572" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma</title>
		<author>
			<persName><forename type="first">D</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mccarthy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Ottensmeier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Hamblin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Stevenson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="2562" to="2568" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Detection of three common translocation breakpoints in non-Hodgkin&apos;s lymphomas by fluorescence in situ hybridization on routine paraffin-embedded tissue sections</title>
		<author>
			<persName><forename type="first">E</forename><surname>Haralambieva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kleiverda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Y</forename><surname>Mason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Schuuring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Kluin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pathol</title>
		<imprint>
			<biblScope unit="volume">198</biblScope>
			<biblScope unit="page" from="163" to="170" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Ventura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Martin-Subero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcparland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gesk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Y</forename><surname>Mason</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Diagn</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="141" to="151" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Translocation (18;22)(q21;q11) in B-cell lymphomas: a report of 4 cases and review of the literature</title>
		<author>
			<persName><forename type="first">P</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jetly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Lennon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">V</forename><surname>Abruzzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Prajapati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Medeiros</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="1664" to="1672" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing</title>
		<author>
			<persName><forename type="first">J</forename><surname>Richter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schlesner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kreuz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Leich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Burkhardt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1316" to="1320" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Dave</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rosenwald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Gascoyne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Chan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">351</biblScope>
			<biblScope unit="page" from="2159" to="2169" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</title>
		<author>
			<persName><forename type="first">A</forename><surname>Subramanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Tamayo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">K</forename><surname>Mootha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mukherjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Ebert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Gillette</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="15545" to="15550" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">STRING v10: protein-protein interaction networks, integrated over the tree of life</title>
		<author>
			<persName><forename type="first">D</forename><surname>Szklarczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Franceschini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wyder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Forslund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Heller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Huerta-Cepas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="D447" to="D452" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">bioDBnet: the biological database network</title>
		<author>
			<persName><forename type="first">U</forename><surname>Mudunuri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Che</forename><forename type="middle">A</forename><surname>Yi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stephens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="555" to="556" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Cluster analysis and display of genome-wide expression patterns</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Eisen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Spellman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">O</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Botstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="14863" to="14868" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Gentles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">V</forename><surname>Nair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Irish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kihira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="1604" to="1611" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours</title>
		<author>
			<persName><forename type="first">K</forename><surname>Karube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Royo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Navarro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pinyol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cazorla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pathol</title>
		<imprint>
			<biblScope unit="volume">234</biblScope>
			<biblScope unit="page" from="423" to="430" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma</title>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Kaminski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yildiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ouillette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jones</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="1487" to="1498" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Morin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mendez-Lago</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Mungall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Goya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Mungall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Corbett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">476</biblScope>
			<biblScope unit="page" from="298" to="303" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma</title>
		<author>
			<persName><forename type="first">J</forename><surname>Okosun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Wolfson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Araf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wilkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Castellano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="183" to="188" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Genetics of follicular lymphoma transformation</title>
		<author>
			<persName><forename type="first">L</forename><surname>Pasqualucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Khiabanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fangazio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vasishtha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Messina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Holmes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="130" to="140" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Activating STAT6 mutations in follicular lymphoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yildiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bernard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Amin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ouillette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jones</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="668" to="679" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Human SLITRK family genes: genomic organization and expression profiling in normal brain and brain tumor tissue</title>
		<author>
			<persName><forename type="first">J</forename><surname>Aruga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yokota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mikoshiba</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene</title>
		<imprint>
			<biblScope unit="volume">315</biblScope>
			<biblScope unit="page" from="87" to="94" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Wholegenome mutational landscape and characterization of noncoding and structural mutations in liver cancer</title>
		<author>
			<persName><forename type="first">A</forename><surname>Fujimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Furuta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Totoki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tsunoda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shiraishi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="500" to="509" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Expression and clinical significance of genes frequently mutated in small cell lung cancers defined by whole exome/RNA sequencing</title>
		<author>
			<persName><forename type="first">R</forename><surname>Iwakawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Totoki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shibata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tsuchihara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mimaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Carcinogenesis</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="616" to="621" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets</title>
		<author>
			<persName><forename type="first">D</forename><surname>Jia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Deng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">Z</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Taylor-Harding</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Lett</title>
		<imprint>
			<biblScope unit="volume">382</biblScope>
			<biblScope unit="page" from="203" to="214" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">HMCN1, a cell polarity-related gene, is somatically mutated in gastric and colorectal cancers</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Je</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Yoo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pathol Oncol Res</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="847" to="848" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mareschal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dubois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Viailly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bertrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bohers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Maingonnat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Chromosomes Cancer</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="251" to="267" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">MicroRNA-202 inhibits tumor progression by targeting LAMA1 in esophageal squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">X</forename><surname>Meng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Yue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Song</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">473</biblScope>
			<biblScope unit="page" from="821" to="827" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">Z</forename><surname>Parris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Danielsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nemes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kovacs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Delle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Fallenius</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="3860" to="3874" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells</title>
		<author>
			<persName><forename type="first">H</forename><surname>Prazeres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rodrigues</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pinto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Pastoriza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gomes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="1302" to="1317" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Epidermal growth factor module-containing mucin-like receptor 2 is a newly identified adhesion G protein-coupled receptor associated with poor overall survival and an invasive phenotype in glioblastoma</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Rutkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Sughrue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Kane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Bloch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Parsa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurooncol</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="165" to="171" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Next generation sequencing in synovial sarcoma reveals novel gene mutations</title>
		<author>
			<persName><forename type="first">M</forename><surname>Vlenterie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Hillebrandt-Roeffen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">E</forename><surname>Flucke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Groenen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Tops</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Kamping</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="34680" to="34690" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib</title>
		<author>
			<persName><forename type="first">G</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Buhrlage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="3237" to="3252" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">IntOGen-mutations identifies cancer drivers across tumor types</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gonzalez-Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Perez-Llamas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Deu-Pons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tamborero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Schroeder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jene</forename><forename type="middle">-</forename><surname>Sanz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Methods</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1081" to="1082" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Terf/TRIM17 stimulates degradation of kinetochore protein ZWINT and regulates cell proliferation</title>
		<author>
			<persName><forename type="first">H</forename><surname>Endo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ikeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Urano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Horie-Inoue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Inoue</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biochem</title>
		<imprint>
			<biblScope unit="volume">151</biblScope>
			<biblScope unit="page" from="139" to="144" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia</title>
		<author>
			<persName><forename type="first">B</forename><surname>Stamatopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Timbs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bruce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Clifford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Robbe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="837" to="845" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Acquired potential N-glycosylation sites within the tumor-specific immunoglobulin heavy chains of B-cell malignancies</title>
		<author>
			<persName><forename type="first">N</forename><surname>Zabalegui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>De Cerio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Inoges</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rodriguez-Calvillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Perez-Calvo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hernandez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="541" to="546" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype</title>
		<author>
			<persName><forename type="first">A</forename><surname>Clipson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>De Leval</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ashton-Key</forename></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wotherspoon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vassiliou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1177" to="1185" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing</title>
		<author>
			<persName><forename type="first">M</forename><surname>Parry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Rose-Zerilli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Ljungstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Walewska</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="4174" to="4183" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">The Kruppellike factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma</title>
		<author>
			<persName><forename type="first">R</forename><surname>Piva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Deaglio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Buonincontri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Scarfo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bruscaggin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="503" to="507" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development</title>
		<author>
			<persName><forename type="first">D</forename><surname>Rossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Trifonov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fangazio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bruscaggin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Spina</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">209</biblScope>
			<biblScope unit="page" from="1537" to="1551" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">The genetics of nodal marginal zone lymphoma</title>
		<author>
			<persName><forename type="first">V</forename><surname>Spina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Khiabanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Messina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Monti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cascione</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bruscaggin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="page" from="1362" to="1373" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">The phosphotyrosyl phosphatase activator gene is a novel p53 target gene</title>
		<author>
			<persName><forename type="first">V</forename><surname>Janssens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Van Hoof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Baere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Merlevede</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Goris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="20488" to="20495" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Knockdown of phosphotyrosyl phosphatase activator induces apoptosis via mitochondrial pathway and the attenuation by simultaneous tau hyperphosphorylation</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Z</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurochem</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="816" to="825" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth</title>
		<author>
			<persName><forename type="first">H</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Granger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Friel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rycroft</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cancer Res</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="859" to="868" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">A</forename><surname>Bouska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Mckeithan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Deffenbacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lachel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Iqbal</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma</title>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="1681" to="1690" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Genetic alterations of histone lysine methyltransferases and their significance in breast cancer</title>
		<author>
			<persName><forename type="first">L</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kimball</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Holowatyj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">Q</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="2466" to="2482" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">ASH1L links histone H3 lysine 36 dimethylation to MLL leukemia</title>
		<author>
			<persName><forename type="first">L</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Discov</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="770" to="783" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Wholeexome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Novak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">W</forename><surname>Asmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Maurer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Slager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Hodge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood Cancer J</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">e346</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Aarts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Bende</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Steenbergen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Kluin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Ooms</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Pals</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="2922" to="2929" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Sugar-coated signaling in follicular lymphoma</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Strout</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="1871" to="1872" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
